Efficient Central Nervous System AAVrh10-mediated Intrathecal Gene Transfer in Adult and Neonate Rats

Overview

Journal Gene Ther

Date 2015 Jan 16

PMID 25588740

Citations 30

Authors

J Hordeaux

L Dubreil

J Deniaud

F Iacobelli

S Moreau

M Ledevin

C Le Guiner

V Blouin

J Le Duff

A Mendes-Madeira

F Rolling

Y Cherel

P Moullier

M-A Colle

Affiliations

Soon will be listed here.

Abstract

Intracerebral administration of recombinant adeno-associated vector (AAV) has been performed in several clinical trials. However, delivery into the brain requires multiple injections and is not efficient to target the spinal cord, thus limiting its applications. To assess widespread and less invasive strategies, we tested intravenous (IV) or intrathecal (that is, in the cerebrospinal fluid (CSF)) delivery of a rAAVrh10-egfp vector in adult and neonate rats and studied the effect of the age at injection on neurotropism. IV delivery is more efficient in neonates and targets predominantly Purkinje cells of the cerebellum and sensory neurons of the spinal cord and dorsal root ganglia. A single intra-CSF administration of AAVrh10, single strand or oversized self-complementary, is efficient for the targeting of neurons in the cerebral hemispheres, cerebellum, brainstem and spinal cord. Green fluorescent protein (GFP) expression is more widespread in neonates when compared with adults. More than 50% of motor neurons express GFP in the three segments of the spinal cord in neonates and in the cervical and thoracic regions in adults. Neurons are almost exclusively transduced in neonates, whereas neurons, astrocytes and rare oligodendrocytes are targeted in adults. These results expand the possible routes of delivery of AAVrh10, a serotype that has shown efficacy and safety in clinical trials concerning neurodegenerative diseases.

Citing Articles

Cis-regulatory elements driving motor neuron-selective viral payload expression within the mammalian spinal cord.

Nagy M, Price S, Wang K, Gill S, Ren E, Jayne L Proc Natl Acad Sci U S A. 2024; 121(49):e2418024121.

PMID: 39602276 PMC: 11626145. DOI: 10.1073/pnas.2418024121.

Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT Receptors Located in the Locus Ceruleus Norepinephrine Neurons.

Lopez-Canul M, He Q, Sasson T, Ettaoussi M, De Gregorio D, Ochoa-Sanchez R J Neurosci. 2024; 44(29).

PMID: 38744530 PMC: 11255427. DOI: 10.1523/JNEUROSCI.0914-23.2024.

Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease.

De B, Rosenberg J, Selvan N, Wilson I, Yusufzai N, Greco A Hum Gene Ther. 2023; 34(17-18):905-916.

PMID: 37624739 PMC: 10517331. DOI: 10.1089/hum.2023.067.

Assessment of AAV9 distribution and transduction in rats after administration through Intrastriatal, Intracisterna magna and Lumbar Intrathecal routes.

Chandran J, Chowdhury E, Perkinton M, Jamier T, Sutton D, Wu S Gene Ther. 2022; 30(1-2):132-141.

PMID: 35637286 DOI: 10.1038/s41434-022-00346-1.

An Approach to Maximize Retrograde Transport Based on the Spatial Distribution of Motor Endplates in Mouse Hindlimb Muscles.

Xu J, Xuan A, Liu Z, Li Y, Zhu J, Yao Y Front Cell Neurosci. 2021; 15:707982.

PMID: 34456685 PMC: 8385196. DOI: 10.3389/fncel.2021.707982.

References

Cearley C, Wolfe J . Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther. 2006; 13(3):528-37. DOI: 10.1016/j.ymthe.2005.11.015. View

Vite C, Passini M, Haskins M, Wolfe J . Adeno-associated virus vector-mediated transduction in the cat brain. Gene Ther. 2003; 10(22):1874-81. DOI: 10.1038/sj.gt.3302087. View

Dong B, Nakai H, Xiao W . Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther. 2009; 18(1):87-92. PMC: 2803017. DOI: 10.1038/mt.2009.258. View

Haurigot V, Marco S, Ribera A, Garcia M, Ruzo A, Villacampa P . Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. J Clin Invest. 2013; 123(8):3254-3271. PMC: 3726158. DOI: 10.1172/JCI66778. View

Hu C, Busuttil R, Lipshutz G . RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy. J Gene Med. 2010; 12(9):766-78. PMC: 2948027. DOI: 10.1002/jgm.1496. View

Zhou X, Zeng X, Fan Z, Li C, McCown T, Samulski R . Adeno-associated virus of a single-polarity DNA genome is capable of transduction in vivo. Mol Ther. 2008; 16(3):494-9. DOI: 10.1038/sj.mt.6300397. View

Wang D, Dayton R, Henning P, Cain C, Zhao L, Schrott L . Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther. 2010; 18(12):2064-74. PMC: 2997590. DOI: 10.1038/mt.2010.191. View

Wang H, Yang B, Qiu L, Yang C, Kramer J, Su Q . Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum Mol Genet. 2013; 23(3):668-81. PMC: 3888258. DOI: 10.1093/hmg/ddt454. View

Haskins M . Gene therapy for lysosomal storage diseases (LSDs) in large animal models. ILAR J. 2009; 50(2):112-21. PMC: 3340575. DOI: 10.1093/ilar.50.2.112. View

10.

Colle M, Piguet F, Bertrand L, Raoul S, Bieche I, Dubreil L . Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate. Hum Mol Genet. 2009; 19(1):147-58. DOI: 10.1093/hmg/ddp475. View

11.

Ciron C, Cressant A, Roux F, Raoul S, Cherel Y, Hantraye P . Human alpha-iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution. Hum Gene Ther. 2009; 20(4):350-60. DOI: 10.1089/hum.2008.155. View

12.

Gray S, Foti S, Schwartz J, Bachaboina L, Taylor-Blake B, Coleman J . Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther. 2011; 22(9):1143-53. PMC: 3177952. DOI: 10.1089/hum.2010.245. View

13.

Swain G, Prociuk M, Bagel J, ODonnell P, Berger K, Drobatz K . Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain. Gene Ther. 2013; 21(1):28-36. PMC: 3881028. DOI: 10.1038/gt.2013.54. View

14.

Klein R, Dayton R, Tatom J, Henderson K, Henning P . AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol Ther. 2007; 16(1):89-96. PMC: 2987640. DOI: 10.1038/sj.mt.6300331. View

15.

Bevan A, Duque S, Foust K, Morales P, Braun L, Schmelzer L . Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther. 2011; 19(11):1971-80. PMC: 3222525. DOI: 10.1038/mt.2011.157. View

16.

Gray S, Nagabhushan Kalburgi S, McCown T, Samulski R . Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 2013; 20(4):450-9. PMC: 3618620. DOI: 10.1038/gt.2012.101. View

17.

Wang Y, Ling C, Song L, Wang L, Aslanidi G, Tan M . Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation. Hum Gene Ther Methods. 2012; 23(4):225-33. PMC: 4015078. DOI: 10.1089/hgtb.2012.090. View

18.

Rabinowitz J, Rolling F, Li C, Conrath H, Xiao W, Xiao X . Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol. 2001; 76(2):791-801. PMC: 136844. DOI: 10.1128/jvi.76.2.791-801.2002. View

19.

Storek B, Harder N, Banck M, Wang C, McCarty D, Janssen W . Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats. Mol Pain. 2006; 2:4. PMC: 1373607. DOI: 10.1186/1744-8069-2-4. View

20.

Towne C, Pertin M, Beggah A, Aebischer P, Decosterd I . Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery. Mol Pain. 2009; 5:52. PMC: 2747840. DOI: 10.1186/1744-8069-5-52. View